Differences in Demographic and Clinical Characteristics Among Subtypes of Female Pattern Hair Loss

References

• Olsen EA. Female pattern hair loss. J Am Acad Dermatol. 2001;45(3 Suppl):S70–80. doi:10.1067/mjd.2001.117426
   PubMed Web of Science ®Google Scholar
• Gan DC, Sinclair RD. Prevalence of male and female pattern hair loss in Maryborough. J Investig Dermatol Symp Proc. 2005;10(3):184–189. doi:10.1111/j.1087-0024.2005.10102.x
   PubMedGoogle Scholar
• Leerunyakul K, Suchonwanit P. Evaluation of hair density and hair diameter in the adult Thai population using quantitative trichoscopic analysis. Biomed Res Int. 2020;2020:2476890. doi:10.1155/2020/2476890
   PubMed Web of Science ®Google Scholar
• Rojhirunsakool S, Suchonwanit P. Parietal scalp is another affected area in female pattern hair loss: an analysis of hair density and hair diameter. Clin Cosmet Investig Dermatol. 2018;11:7–12. doi:10.2147/ccid.S153768
   PubMed Web of Science ®Google Scholar
• Natpracha W, Sukanjanapong S, Chanprapaph K, Suchonwanit P. Characterization and classification of different female hairline patterns in the Thai population. J Cosmet Dermatol. 2021;20(3):890–896. doi:10.1111/jocd.13642
   PubMed Web of Science ®Google Scholar
• Iamsumang W, Leerunyakul K, Suchonwanit P. Finasteride and its potential for the treatment of female pattern hair loss: evidence to date. Drug Des Devel Ther. 2020;14:951–959. doi:10.2147/dddt.S240615
   PubMed Web of Science ®Google Scholar
• Khunkhet S, Chanprapaph K, Rutnin S, Suchonwanit P. Histopathological evidence of occipital involvement in male androgenetic alopecia. Front Med. 2021;8:790597. doi:10.3389/fmed.2021.790597
   Web of Science ®Google Scholar
• Suchonwanit P, Iamsumang W, Rojhirunsakool S. Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: a Randomized, Double-Blind, Controlled Study. Am J Clin Dermatol. 2019;20(1):147–153. doi:10.1007/s40257-018-0387-0
   PubMed Web of Science ®Google Scholar
• Suchonwanit P, Iamsumang W, Leerunyakul K. Topical finasteride for the treatment of male androgenetic alopecia and female pattern hair loss: a review of the current literature. J Dermatolog Treat. 2022;33(2):643–648. doi:10.1080/09546634.2020.1782324
   PubMed Web of Science ®Google Scholar
• Chanprapaph K, Sutharaphan T, Suchonwanit P. Scalp biophysical characteristics in males with androgenetic alopecia: a comparative study with healthy controls. Clin Interv Aging. 2021;16:781–787. doi:10.2147/cia.S310178
   PubMed Web of Science ®Google Scholar
• Suchonwanit P, Triyangkulsri K, Ploydaeng M, Leerunyakul K. Assessing biophysical and physiological profiles of scalp seborrheic dermatitis in the Thai population. Biomed Res Int. 2019;2019:5128376. doi:10.1155/2019/5128376
   PubMed Web of Science ®Google Scholar
• Vañó-Galván S, Saceda-Corralo D, Blume-Peytavi U, et al. Frequency of the types of alopecia at twenty-two specialist hair clinics: a multicenter study. Skin Appendage Disorders. 2019;5(5):309–315. doi:10.1159/000496708
   PubMed Web of Science ®Google Scholar
• Arias-Santiago S, Gutiérrez-Salmerón MT, Castellote-Caballero L, Buendía-Eisman A, Naranjo-Sintes R. Androgenetic alopecia and cardiovascular risk factors in men and women: a comparative study. J Am Acad Dermatol. 2010;63(3):420–429. doi:10.1016/j.jaad.2009.10.018
   PubMed Web of Science ®Google Scholar
• Yi SM, Son SW, Lee KG, et al. Gender-specific association of androgenetic alopecia with metabolic syndrome in a middle-aged Korean population. Br J Dermatol. 2012;167(2):306–313. doi:10.1111/j.1365-2133.2012.10978.x
   PubMed Web of Science ®Google Scholar
• Liamsombut S, Pomsoong C, Kositkuljorn C, Leerunyakul K, Tantrakul V, Suchonwanit P. Sleep quality in men with androgenetic alopecia. Sleep Breath. 2023;27(1):371–378. doi:10.1007/s11325-022-02618-x
   PubMed Web of Science ®Google Scholar
• Suchonwanit P, Kositkuljorn C, Mahasaksiri T, Leerunyakul K. A comparison of the efficacy and tolerability of three corticosteroid treatment regimens in patients with alopecia areata. J Dermatolog Treat. 2022;33(2):756–761. doi:10.1080/09546634.2020.1773384
   PubMed Web of Science ®Google Scholar
• Suchonwanit P, McMichael AJ. Alopecia in Association with Malignancy: a Review. Am J Clin Dermatol. 2018;19(6):853–865. doi:10.1007/s40257-018-0378-1
   PubMed Web of Science ®Google Scholar
• Özkoca D, Aşkın Ö, Engin B. The comparison of demographics and comorbidities of female pattern hair loss according to the clinical subtype and stage. J Am Acad Dermatol. 2022;87(4):779–783. doi:10.1016/j.jaad.2021.11.027
   PubMed Web of Science ®Google Scholar
• Tandon S, Arora P, Gautam RK, Bhardwaj M, Garga U, Sharma N. Correlation between Clinical Features, Biochemical Parameters, and Histopathological Findings in Women with Patterned Baldness: a Study from North India. J Cutan Aesthet Surg. 2019;12(1):42–48. doi:10.4103/jcas.Jcas_30_18
   PubMedGoogle Scholar
• Paik JH, Yoon JB, Sim WY, Kim BS, Kim NI. The prevalence and types of androgenetic alopecia in Korean men and women. Br J Dermatol. 2001;145(1):95–99. doi:10.1046/j.1365-2133.2001.04289.x
   PubMed Web of Science ®Google Scholar
• Blumeyer A, Tosti A, Messenger A, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. J Dtsch Dermatol Ges. 2011;9(6):S1–57. doi:10.1111/j.1610-0379.2011.07802.x
   PubMedGoogle Scholar
• Norwood OT. Male pattern baldness: classification and incidence. South Med J. 1975;68(11):1359–1365. doi:10.1097/00007611-197511000-00009
   PubMed Web of Science ®Google Scholar
• Hamilton JB. Patterned loss of hair in man; types and incidence. Ann N Y Acad Sci. 1951;53(3):708–728. doi:10.1111/j.1749-6632.1951.tb31971.x
   PubMed Web of Science ®Google Scholar
• Ramos PM, Miot HA. Female Pattern Hair Loss: a clinical and pathophysiological review. An Bras Dermatol. 2015;90(4):529–543. doi:10.1590/abd1806-4841.20153370
   PubMed Web of Science ®Google Scholar
• Su LH, Chen LS, Chen HH. Factors associated with female pattern hair loss and its prevalence in Taiwanese women: a community-based survey. J Am Acad Dermatol. 2013;69(2):e69–77. doi:10.1016/j.jaad.2012.09.046
   PubMed Web of Science ®Google Scholar
• Salman KE, Altunay IK, Kucukunal NA, Cerman AA. Frequency, severity and related factors of androgenetic alopecia in dermatology outpatient clinic: hospital-based cross-sectional study in Turkey. An Bras Dermatol. 2017;92(1):35–40. doi:10.1590/abd1806-4841.20175241
   PubMed Web of Science ®Google Scholar
• Khumalo NP, Jessop S, Gumedze F, Ehrlich R. Hairdressing and the prevalence of scalp disease in African adults. Br J Dermatol. 2007;157(5):981–988. doi:10.1111/j.1365-2133.2007.08146.x
   PubMed Web of Science ®Google Scholar
• Lee WS, Lee HJ. Characteristics of androgenetic alopecia in asian. Ann Dermatol. 2012;24(3):243–252. doi:10.5021/ad.2012.24.3.243
   PubMed Web of Science ®Google Scholar
• Herskovitz I, Tosti A. Female pattern hair loss. Int J Endocrinol Metab. 2013;11(4):e9860. doi:10.5812/ijem.9860
   PubMedGoogle Scholar
• Redler S, Messenger AG, Betz RC. Genetics and other factors in the aetiology of female pattern hair loss. Exp Dermatol. 2017;26(6):510–517. doi:10.1111/exd.13373
   PubMed Web of Science ®Google Scholar
• Starace M, Orlando G, Alessandrini A, Piraccini BM. Female Androgenetic Alopecia: an Update on Diagnosis and Management. Am J Clin Dermatol. 2020;21(1):69–84. doi:10.1007/s40257-019-00479-x
   PubMed Web of Science ®Google Scholar
• Rossi A, D’Arino A, Pigliacelli F, et al. The diagnosis of androgenetic alopecia in children: considerations of pathophysiological plausibility. Australas J Dermatol. 2019;60(4):e279–e283. doi:10.1111/ajd.13079
   PubMed Web of Science ®Google Scholar
• Leerunyakul K, Suchonwanit P. Asian Hair: a Review of Structures, Properties, and Distinctive Disorders. Clin Cosmet Investig Dermatol. 2020;13:309–318. doi:10.2147/ccid.S247390
   PubMed Web of Science ®Google Scholar
• Randolph JF, Zheng H, Sowers MR, et al. Change in follicle-stimulating hormone and estradiol across the menopausal transition: effect of age at the final menstrual period. J Clin Endocrinol Metab. 2011;96(3):746–754. doi:10.1210/jc.2010-1746
   PubMed Web of Science ®Google Scholar
• Carmina E, Azziz R, Bergfeld W, et al. Female Pattern Hair Loss and Androgen Excess: a Report From the Multidisciplinary Androgen Excess and PCOS Committee. J Clin Endocrinol Metab. 2019;104(7):2875–2891. doi:10.1210/jc.2018-02548
   PubMed Web of Science ®Google Scholar
• Feng JG, Guo Y, Ma LA, Xing J, Sun RF, Zhu W. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China. J Cosmet Dermatol. 2018;17(3):511–517. doi:10.1111/jocd.12387
   PubMed Web of Science ®Google Scholar
• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25. doi:10.1016/j.fertnstert.2003.10.004
   Web of Science ®Google Scholar
• Matilainen V, Laakso M, Hirsso P, Koskela P, Rajala U, Keinänen-Kiukaanniemi S. Hair loss, insulin resistance, and heredity in middle-aged women. A population-based study. J Cardiovasc Risk. 2003;10(3):227–231. doi:10.1097/01.hjr.0000070200.72977.c6
   PubMedGoogle Scholar